# Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer

> **NCT02036918** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 20 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Sipuleucel-T
- **PROCEDURE:** Lymph Node Biopsy

## Key facts

- **NCT ID:** NCT02036918
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2019-02-06
- **Final completion:** 2019-02-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02036918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02036918, "Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02036918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*